Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCI...
Q1 2026
May 13, 2026
FY 2025
Mar 18, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 14, 2025